Cargando…
Effect of Obesity on Clinical Failure of Patients Treated With β-Lactams
BACKGROUND: Altered pharmacokinetics in obese patients raise concerns over worse clinical outcomes. This study assessed whether obese patients receiving a β-lactam have worse clinical outcomes compared to nonobese patients and to identify if therapeutic drug monitoring may be beneficial. METHODS: Th...
Autores principales: | Pinner, Nathan A, Tapley, Natalie G, Barber, Katie E, Stover, Kayla R, Wagner, Jamie L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391092/ https://www.ncbi.nlm.nih.gov/pubmed/34458387 http://dx.doi.org/10.1093/ofid/ofab212 |
Ejemplares similares
-
Impact of Obesity on Acyclovir-Induced Nephrotoxicity
por: Barber, Katie E, et al.
Publicado: (2019) -
1380. Effect of Absolute Body Weight on Clinical Outcomes of Obese Patients Treated with Cefepime
por: Wagner, Jamie L, et al.
Publicado: (2018) -
Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients Who Are Morbidly Obese
por: Kunz Coyne, Ashlan J, et al.
Publicado: (2023) -
The Impact of Reported β-Lactam Allergy on Clinical Outcomes and Antibiotic Use Among Solid Organ Transplant Recipients
por: Zhang, Helen L, et al.
Publicado: (2022) -
The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-Lactams
por: Dufour, Nicolas, et al.
Publicado: (2017)